AN2 Therapeutics, Inc. (ANTX)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-09-15 | Trenor Cameron C. III | officer | A | 116,667 | 0 | $0 |
| 2026-09-09 | Readnour Robin Shane | director | S | 585 | 6.02 | $3,524 |
| 2026-09-09 | Readnour Robin Shane | director | S | 523 | 6.02 | $3,151 |
| 2026-09-08 | Readnour Robin Shane | director | S | 5,294 | 6.02 | $31,861 |
| 2026-09-08 | Readnour Robin Shane | director | S | 4,725 | 6.02 | $28,436 |
| 2026-09-03 | Readnour Robin Shane | director | S | 3,223 | 6.07 | $19,563 |
| 2026-09-03 | Readnour Robin Shane | director | S | 2,877 | 6.07 | $17,463 |
| 2026-09-01 | Williams Sarah Joanne | officer | S | 272 | 5.53 | $1,504 |
| 2026-09-01 | FitzPatrick Margaret M | director | P | 2,098 | 5.53 | $11,602 |
| 2026-08-17 | Readnour Robin Shane | director | S | 16,696 | 6.01 | $100,313 |
| 2026-08-17 | Readnour Robin Shane | director | S | 18,706 | 6.01 | $112,389 |
| 2026-08-14 | Zakrzewski Joseph S | director | G | 405,880 | 0 | $0 |
| 2026-07-10 | Aziz Kabeer | director | A | 2,852 | 0 | $0 |
| 2026-07-10 | Marks Gilbert Lynn | director | A | 2,789 | 0 | $0 |
| 2026-07-10 | Martin Patricia A. | director | A | 766 | 0 | $0 |
| 2026-07-08 | Eizen Joshua M | officer | S | 5,945 | 4.17 | $24,803 |
| 2026-05-29 | Williams Sarah Joanne | officer | S | 265 | 4.43 | $1,174 |
| 2026-05-29 | Williams Sarah Joanne | officer | S | 265 | 4.43 | $1,174 |
| 2026-04-10 | Aziz Kabeer | director | A | 3,775 | 0 | $0 |
| 2026-04-10 | Marks Gilbert Lynn | director | A | 3,775 | 0 | $0 |
| 2026-04-10 | Martin Patricia A. | director | A | 1,192 | 0 | $0 |
| 2026-04-10 | Aziz Kabeer | director | A | 3,775 | 0 | $0 |
| 2026-04-10 | Marks Gilbert Lynn | director | A | 3,775 | 0 | $0 |
| 2026-04-10 | Martin Patricia A. | director | A | 1,192 | 0 | $0 |
| 2026-03-03 | Williams Sarah Joanne | officer | S | 327 | 1.06 | $347 |
| 2026-03-03 | Williams Sarah Joanne | officer | S | 327 | 1.06 | $347 |
| 2026-02-20 | Eizen Joshua M | officer | A | 50,000 | 0 | $0 |
| 2026-02-20 | Day Lucy | officer | A | 38,000 | 0 | $0 |
| 2026-02-20 | Williams Sarah Joanne | officer | A | 48,375 | 0 | $0 |
| 2026-02-20 | Easom Eric | director | A | 112,250 | 0 | $0 |
| 2026-02-20 | Chanda Sanjay | officer | A | 38,000 | 0 | $0 |
| 2026-02-20 | Eizen Joshua M | officer | A | 50,000 | 0 | $0 |
| 2026-02-20 | Day Lucy | officer | A | 38,000 | 0 | $0 |
| 2026-02-20 | Williams Sarah Joanne | officer | A | 48,375 | 0 | $0 |
| 2026-02-20 | Easom Eric | director | A | 112,250 | 0 | $0 |
| 2026-02-20 | Chanda Sanjay | officer | A | 38,000 | 0 | $0 |
| 2026-01-12 | Aziz Kabeer | director | A | 11,560 | 0 | $0 |
| 2026-01-12 | Martin Patricia A. | director | A | 3,650 | 0 | $0 |
| 2026-01-12 | Marks Gilbert Lynn | director | A | 11,560 | 0 | $0 |
| 2026-01-12 | Aziz Kabeer | director | A | 11,560 | 0 | $0 |
| 2026-01-12 | Martin Patricia A. | director | A | 3,650 | 0 | $0 |
| 2026-01-12 | Marks Gilbert Lynn | director | A | 11,560 | 0 | $0 |
| 2026-01-06 | Day Lucy | officer | S | 5,512 | 1.01 | $5,567 |
| 2026-01-06 | Prior Stephen David | officer | S | 2,858 | 1.01 | $2,887 |
| 2026-01-06 | Chanda Sanjay | officer | S | 5,956 | 1.01 | $6,016 |
| 2026-01-06 | Eizen Joshua M | officer | S | 6,931 | 1.01 | $7,000 |
| 2026-01-06 | Day Lucy | officer | S | 5,512 | 1.01 | $5,578 |
| 2026-01-06 | Prior Stephen David | officer | S | 2,858 | 1.01 | $2,892 |
| 2026-01-06 | Chanda Sanjay | officer | S | 5,956 | 1.01 | $6,027 |
| 2026-01-06 | Eizen Joshua M | officer | S | 6,931 | 1.01 | $7,014 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
No Wikipedia pageview data linked to this company.